Anteris Technologies Ltd (AMEUF) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Toowong, QLD, Australia. The current CEO is Wayne Geoffrey Paterson.
AMEUF has IPO date of 2013-12-09, listed on the Other OTC, a market capitalization of $120.5M.
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
